Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older
about
Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older
description
clinical trial
@en
klinisch onderzoek
@nl
name
Safety and Immunogenicity Stud ...... ts of 40 Years of Age or Older
@en
type
label
Safety and Immunogenicity Stud ...... ts of 40 Years of Age or Older
@en
prefLabel
Safety and Immunogenicity Stud ...... ts of 40 Years of Age or Older
@en
P1050
P1476
An Open-label, Multicentre Stu ...... oster Within the Last 20 Years
@en
P3098
NCT01287949
P580
2011-01-01T00:00:00Z
P582
2012-05-01T00:00:00Z